Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 15, 2006
Reporting Period: This filing announces financial results for the quarter and full year ended December 31, 2005. The detailed results are contained in the press release furnished as Exhibit 99.1.
Key Financial Metrics
The Form 8-K text serves as a notification of results and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached press release (Exhibit 99.1).
The filing highlights the use of the following non-GAAP financial measures to supplement GAAP results:
- Income from continuing operations excluding Medicare lab recoveries related to prior years' services.
- Operating income excluding Medicare lab recoveries related to prior years' services.
- Operating cash flow excluding Medicare lab recoveries and tax benefits from stock option exercises.
- Free cash flow (with and without exclusions for Medicare lab recoveries and tax benefits).
- Operating revenue excluding Medicare lab recoveries related to prior years' services.
- Consolidated EBITDA (as defined in the credit agreement effective October 5, 2005) for debt leverage ratio calculations.
Material Changes
The filing text does not provide specific data on material changes versus prior periods. It notes that the company historically reports non-GAAP measures to exclude non-recurring expenses and Medicare lab recoveries, which can cause unusual fluctuations in operating performance, thereby providing consistency and comparability to prior periods.
Guidance, Outlook, and Risks
Outlook: The attached press release contains forward-looking statements regarding operating performance for 2006.
Risks and Uncertainties: Management states that forward-looking statements involve substantial known and unknown risks that could cause actual results to differ materially from expectations. These risks are detailed in the Company's most recent Form 10-Q (quarter ended September 30, 2005) and Form 10-K (year ended December 31, 2004).
Unusual Items: The filing explicitly identifies "Medicare lab recoveries related to prior years' services" as items that may not be indicative of normal operating results and are excluded from certain non-GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for Q4 and FY 2005.
- Verify the reconciliation of non-GAAP measures to GAAP measures provided in the press release.
- Examine the credit agreement effective October 5, 2005, to understand the definition of Consolidated EBITDA used for debt covenants.
- Consult the Form 10-Q (ended Sept 30, 2005) and Form 10-K (ended Dec 31, 2004) for detailed risk factors affecting the 2006 outlook.
- Assess the impact of Medicare lab recoveries on historical operating performance trends.